BRIEF-ImmunoCellular Therapeutics says appointed David Fractor as CFO
April 20, 2017 at 16:51 PM EDT
* ImmunoCellular Therapeutics - on April 14 board appointed David Fractor as chief financial officer of co, effective immediately - SEC filing Source text - http://bit.ly/2ortrfl Further company coverage:
